comparemela.com

Invitae (NYSE:NVTA – Get Rating) had its price target decreased by Piper Sandler from $1.75 to $1.50 in a research report released on Monday, The Fly reports. A number of other analysts have also weighed in on the stock. StockNews.com began coverage on shares of Invitae in a research note on Thursday, March 16th. They […]

Related Keywords

San Francisco ,California ,United States ,Robertl Nussbaum ,Randalw Scott ,Piper Sandler ,Seane George ,Raymond James ,Yafei Wen ,Invitae Corp ,Invitae Company Profile ,Arete Wealth Advisors ,Securities Exchange Commission ,Goldman Sachs Group ,Get Rating ,Exchange Commission ,Advocates Investment Management ,Investment Advisers ,Wealth Advisors ,Aries Wealth Management ,Invitae Daily ,Invitae ,Nyse Nvta ,Nvta ,Medical ,Lower Price Target ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.